Remus Pharmaceuticals P/E Ratio
Current P/E Ratio
18.83
Moderate Valuation
Moderate - Fairly valued
Remus Pharmaceuticals (REMUS) P/E ratio is 18.83 (Moderate), EPS (TTM) ₹39.19, current price ₹ on None — Moderate - Fairly valued. See Remus Pharmaceuticals P/B ratio trends to compare market price against book value per share.
Current Valuation Metrics
P/E Ratio
18.83
Current Price
₹
EPS (TTM)
₹39.19
Exchange
None
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
55.83
Sector Median
31.44
Sector Rank
#11 of 194
Sector Percentile
5.7%
REMUS P/E Ratio — Valuation Signal & Historical Context
Remus Pharmaceuticals P/E 18.83 — signal: Fairly Valued. Read REMUS dividend growth for the complete payout history and dividend yield track record.
- Trading at discount to sector average PE of 55.83
REMUS vs Healthcare Peers — P/E Ratio Comparison
Remus Pharmaceuticals P/E 18.83 vs Healthcare average 55.83, median 31.44 — range 2.86–916.67.
Sector Average
55.83
Sector Median
31.44
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.76 | ₹30 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| Shelter Pharma | SHELTER | 5.23 | ₹47 | Low |
| Dipna Pharmachem | DPL | 5.39 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.41 | ₹68 | Low |
| Amwill Health Care | AMWILL | 7.26 | ₹83 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹84 | Low |
| Galaxy Medicare | GML | 7.8 | ₹27 | Low |